BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36944577)

  • 1. Inhibition of Integrin α
    Huang L; Zhu Y; Kong Q; Guan X; Lei X; Zhang L; Yang H; Yao X; Liang S; An X; Yu J
    Cell Adh Migr; 2023 Dec; 17(1):1-14. PubMed ID: 36944577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The integrin alpha5beta1 regulates alphavbeta3-mediated extracellular signal-regulated kinase activation.
    Ly DP; Corbett SA
    J Surg Res; 2005 Feb; 123(2):200-5. PubMed ID: 15680379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin increases migration and MMP-9 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells.
    Chen YJ; Wei YY; Chen HT; Fong YC; Hsu CJ; Tsai CH; Hsu HC; Liu SH; Tang CH
    J Cell Physiol; 2009 Oct; 221(1):98-108. PubMed ID: 19475568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfatide interacts with and activates integrin αVβ3 in human hepatocellular carcinoma cells.
    Wang R; Qi B; Dong YW; Cai QQ; Deng NH; Chen Q; Li C; Jin YT; Wu XZ
    Oncotarget; 2016 Jun; 7(24):36563-36576. PubMed ID: 27145276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor beta1 induces alphavbeta3 integrin expression in human lung fibroblasts via a beta3 integrin-, c-Src-, and p38 MAPK-dependent pathway.
    Pechkovsky DV; Scaffidi AK; Hackett TL; Ballard J; Shaheen F; Thompson PJ; Thannickal VJ; Knight DA
    J Biol Chem; 2008 May; 283(19):12898-908. PubMed ID: 18353785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of ROS-alpha v beta 3 integrin-FAK/Pyk2 in the inhibitory effect of melatonin on U251 glioma cell migration and invasion under hypoxia.
    Xu CS; Wang ZF; Huang XD; Dai LM; Cao CJ; Li ZQ
    J Transl Med; 2015 Mar; 13():95. PubMed ID: 25889845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear αvβ3 integrin expression, post translational modifications and regulation in hematological malignancies.
    Weisz A; Abadi U; Mausbach L; Gurwitz D; Ellis M; Ashur-Fabian O
    Hematol Oncol; 2022 Feb; 40(1):72-81. PubMed ID: 34534368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling.
    Luo J; Yao JF; Deng XF; Zheng XD; Jia M; Wang YQ; Huang Y; Zhu JH
    J Exp Clin Cancer Res; 2018 Feb; 37(1):23. PubMed ID: 29426357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant RGD-disintegrin DisBa-01 blocks integrin α
    Danilucci TM; Santos PK; Pachane BC; Pisani GFD; Lino RLB; Casali BC; Altei WF; Selistre-de-Araujo HS
    Cell Commun Signal; 2019 Mar; 17(1):27. PubMed ID: 30894182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disintegrin Tablysin-15 Suppresses Cancer Hallmarks in Melanoma Cells by Blocking FAK/Akt/ERK and NF-κB Signaling.
    Deng Z; Zeng Q; Chai J; Zhang B; Zheng W; Xu X; Wu J
    Curr Cancer Drug Targets; 2020; 20(4):306-315. PubMed ID: 31893992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PERIOSTIN regulates MMP-2 expression via the αvβ3 integrin/ERK pathway in human periodontal ligament cells.
    Watanabe T; Yasue A; Fujihara S; Tanaka E
    Arch Oral Biol; 2012 Jan; 57(1):52-9. PubMed ID: 21885032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of beta1-integrin enhances TGF-beta1-induced collagen expression in epithelial cells via increased alphavbeta3-integrin and Rac1 activity.
    Hayashida T; Jones JC; Lee CK; Schnaper HW
    J Biol Chem; 2010 Oct; 285(40):30741-51. PubMed ID: 20650890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BKCa promotes growth and metastasis of prostate cancer through facilitating the coupling between αvβ3 integrin and FAK.
    Du C; Zheng Z; Li D; Chen L; Li N; Yi X; Yang Y; Guo F; Liu W; Xie X; Xie M
    Oncotarget; 2016 Jun; 7(26):40174-40188. PubMed ID: 27233075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation.
    Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
    Mol Cancer; 2005 Oct; 4():37. PubMed ID: 16209712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteopontin increases lung cancer cells migration via activation of the alphavbeta3 integrin/FAK/Akt and NF-kappaB-dependent pathway.
    Fong YC; Liu SC; Huang CY; Li TM; Hsu SF; Kao ST; Tsai FJ; Chen WC; Chen CY; Tang CH
    Lung Cancer; 2009 Jun; 64(3):263-70. PubMed ID: 18996613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain-derived neurotrophic factor induces migration of endothelial cells through a TrkB-ERK-integrin αVβ3-FAK cascade.
    Matsuda S; Fujita T; Kajiya M; Takeda K; Shiba H; Kawaguchi H; Kurihara H
    J Cell Physiol; 2012 May; 227(5):2123-9. PubMed ID: 21769870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological inhibition of the vitronectin receptor abrogates PDGF-BB-induced hepatic stellate cell migration and activation in vitro.
    Patsenker E; Popov Y; Wiesner M; Goodman SL; Schuppan D
    J Hepatol; 2007 May; 46(5):878-87. PubMed ID: 17258347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The thyroid hormone-αvβ3 integrin axis in ovarian cancer: regulation of gene transcription and MAPK-dependent proliferation.
    Shinderman-Maman E; Cohen K; Weingarten C; Nabriski D; Twito O; Baraf L; Hercbergs A; Davis PJ; Werner H; Ellis M; Ashur-Fabian O
    Oncogene; 2016 Apr; 35(15):1977-87. PubMed ID: 26165836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated αvβ3 integrin regulates αvβ5 integrin-mediated phagocytosis in trabecular meshwork cells.
    Gagen D; Filla MS; Clark R; Liton P; Peters DM
    Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):5000-11. PubMed ID: 23821196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair.
    Christmann M; Diesler K; Majhen D; Steigerwald C; Berte N; Freund H; Stojanović N; Kaina B; Osmak M; Ambriović-Ristov A; Tomicic MT
    Oncotarget; 2017 Apr; 8(17):27754-27771. PubMed ID: 27487141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.